高龄胆源性急性胰腺炎的内镜治疗  

Endoscopic therapy for aged patients with biliary acute pancreatitis

作　　者：苏进根[1] 王建平[1] 陆奕宁[1] 陆惠清[1] 朱堃[1] 陈跃宇[1] 

机构地区：[1]上海交通大学附属仁济医院嘉定分院上海市嘉定区中心医院普外科,201800

出　　处：《腹部外科》2012年第2期97-99,共3页Journal of Abdominal Surgery

基　　金：基金项目：上海市嘉定区卫生局科研基金资助项目（No.20071101）

摘　　要：目的探讨高龄胆源性急性胰腺炎（biliary acute pancreatitis，BAP）病人早期内镜治疗的疗效及安全性。方法将100例BAP病人分为高龄组（80岁及以上）22例，对照组（80岁以下）78例，观察两组内镜治疗的疗效和安全性。结果高龄组22例均顺利完成了内镜下逆行胰胆管造影（ERCP）操作，与对照组比较，治疗后血淀粉酶、白细胞计数、肝功能恢复正常时间、腹痛缓解时间、腹部体征消失时间及体温恢复正常时间、并发症发生率等差异均无统计学意义。结论治疗性ERCP对于治疗高龄BAP具有微创、安全、有效等优点。Objective To evaluate the safety and effect of early therapeutic endoscopic retrograde cholangiopancreatography（ERCP） for aged patients with biliary acute pancreatitis（BAP）. Methotis The clinical data of 100 patients with BAP were analyzed. The patients were divided into aged group（≥80 years,n = 22）,and control group（〈80 years,n = 78）. Results All 22 aged patients receiving ERCP successfully underwent the examination and therapy. The days of normalization of serum amylase, leukocyte, hepatic function indexes, body temperature, and relief of abdominal pains and signs had no significant difference between two groups. All patients were cured, and no ERCP-related severe complications occurred. Conclusion ERCP is minimally invasive, safe and highly effective in the treatment of BAP.

关 键 词：胰腺炎 老年人 80岁以上 胰胆管造影术 内窥镜逆行 

分 类 号：R657.51[医药卫生—外科学]